A phone call from a survivor: could peer support calm transplant anxiety?

NCT ID NCT07774104

NEW Not yet recruiting Symptom relief Sponsor: Brigham and Women's Hospital Source: ClinicalTrials.gov ↗

First seen Aug 19, 2026 · Last updated Aug 19, 2026

Summary

This trial tests whether a structured peer support program, called STEPP, can reduce anxiety and improve quality of life in adults undergoing stem cell transplantation for blood cancers. Participants receive five phone sessions with a trained transplant survivor, blending cognitive-behavioral, mindfulness, and positive psychology techniques. The study compares their outcomes to those receiving standard care, focusing on anxiety levels at eight weeks.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: STEPP, a phone-delivered structured peer support program
What this could lead to: If effective, this could establish peer support as a standard part of care to ease psychological distress in stem cell transplant patients.
What could go wrong: The trial is relatively small and the intervention is behavioral, so effects may be modest or not generalizable. There are no physical risks, but benefits may vary.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEMATOLOGIC MALIGNANCIES are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

hematopoietic and lymphoid cell neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HEMATOPOIETIC STEM CELL TRANSPLANTATION

Contacts and locations

Locations

Dana-Farber Cancer Institute

Boston, Massachusetts, 02215, United States
Fred Hutchinson Cancer Center

Seattle, Washington, 98109, United States
Moffitt Cancer Center

Tampa, Florida, 33612, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.